ReShape unveils positive results from DBSN device preclinical trials
In the study, treatment using the DBSN device was well-tolerated in the T2DM patients
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Sep 20
In the study, treatment using the DBSN device was well-tolerated in the T2DM patients
GlobalData estimates the market for continuous glucose monitors will grow in 2020 compared to last year — regardless…
19 Aug 20
Through the support of the DOD research grant, MedShape will explore the development of novel devices that maintain…
12 Aug 20
InPen is said to be the only US FDA-approved smart insulin pen system combined with an integrated diabetes…
31 Jul 20
Jim Banks explores the healthcare potential of 'stretchable electronics' with Matt Pharr, assistant professor of mechanical engineering at…
28 Jul 20
Healthimation is engaged in the commercialisation of an application-based diabetes prevention programme
14 Jul 20
The pilot offers a combination of real-time glucose monitoring, lifestyle changes and one-on-one coaching to help people stabilize…
10 Jul 20
With certain exclusions, this agreement applies to the companies’ existing products, as well as new products for at…
02 Jul 20
Gvoke HypoPen is the first ready-to-use glucagon in a premixed autoinjector, with no visible needle
01 Jul 20
The leader in self-monitoring of blood glucose in France will distribute Mallya connected device to pharmacists and will…